Go Back

Wellington Management

Wellington Management, a venture fund established in 1933 in Boston, Massachusetts, has a diverse investment focus across various sectors including Parenting, Healthcare, E-Commerce, and FinTech. With investments in 205 companies and 106 exits, the fund covers stages from Seed to Series D. Andrew Heiskell is a key partner at Wellington Management, overseeing a portfolio that includes companies like Kinside, Course Hero, and Trove. The fund's commitment to meeting institutional clients' needs sets it apart in the investment management landscape. For more information, visit their website at wellington.com.

About

About

About

Bio

Wellington Management focuses on investment management by applying its full resources to meet the needs of institutional clients they serve.

Location

Boston, Massachusetts

Stage

Seed, Series A, Series B, Series C, Series D

Partner name

Andrew Heiskell

Bio

Wellington Management focuses on investment management by applying its full resources to meet the needs of institutional clients they serve.

Location

Boston, Massachusetts

Stage

Seed, Series A, Series B, Series C, Series D

Partner name

Andrew Heiskell

Fund

Fund

Fund

Fund Focus

Parenting, Information Technology, Healthcare, Medical Device, Health & Wellness, EdTech, SaaS, B2B, Big Data & Analytics, E-Commerce, Marketing (MarTech), Food and Beverage, Hospitality, Marketplace, Fashion, RetailTech, PropTech, Consumer, Consumer Goods, Travel, Energy, Hardware, IoT (Internet of Things), ClimateTech & CleanTech, Software, BioTech, Life Science, Advertising (AdTech), Developer Tools, Enterprise, FinTech

Number of investments

205

Number of exits

106

Fund Type

Venture Fund

Portfolio Companies

Kinside, Somatus, Course Hero, ROKT, ezCater, Trove, Sundae, Away, Span.IO, Harry's, Artiva Biotherapeutics, Strata Oncology, Nanigans, CodeSee, Fintiv, Chroma Medicine, Acrivon Therapeutics, Goldfinch Biopharma, General Assembly, Asher Bio

Wellington Management

Wellington Management, a venture fund established in 1933 in Boston, Massachusetts, has a diverse investment focus across various sectors including Parenting, Healthcare, E-Commerce, and FinTech. With investments in 205 companies and 106 exits, the fund covers stages from Seed to Series D. Andrew Heiskell is a key partner at Wellington Management, overseeing a portfolio that includes companies like Kinside, Course Hero, and Trove. The fund's commitment to meeting institutional clients' needs sets it apart in the investment management landscape. For more information, visit their website at wellington.com.

About

Bio

Wellington Management focuses on investment management by applying its full resources to meet the needs of institutional clients they serve.

Location

Boston, Massachusetts

Stage

Seed, Series A, Series B, Series C, Series D

Partner name

Andrew Heiskell

Fund

Fund Focus

Parenting, Information Technology, Healthcare, Medical Device, Health & Wellness, EdTech, SaaS, B2B, Big Data & Analytics, E-Commerce, Marketing (MarTech), Food and Beverage, Hospitality, Marketplace, Fashion, RetailTech, PropTech, Consumer, Consumer Goods, Travel, Energy, Hardware, IoT (Internet of Things), ClimateTech & CleanTech, Software, BioTech, Life Science, Advertising (AdTech), Developer Tools, Enterprise, FinTech

Number of investments

205

Number of exits

106

Fund Type

Venture Fund

Portfolio Companies

Kinside, Somatus, Course Hero, ROKT, ezCater, Trove, Sundae, Away, Span.IO, Harry's, Artiva Biotherapeutics, Strata Oncology, Nanigans, CodeSee, Fintiv, Chroma Medicine, Acrivon Therapeutics, Goldfinch Biopharma, General Assembly, Asher Bio